Vaccines against Lassa fever virus (VITAL): Phase 1 safety and immunogenicity studies of a Lassa fever vaccine, ChAdOx1 LassaJ, in healthy volunteers in the UK and Ghana
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access
10.37432/jieph-confpro5-00111Full text0 citations